-prazole
A proton pump inhibitor: cuts stomach acid by blocking the pump in the stomach lining that secretes it.
- Drugs ending in -prazole: 15
- Approved somewhere: 10
- With a US drug page: 8
- Stem
- -prazole
- Class
- Proton pump inhibitors with a benzimidazole core, like omeprazole
- Sub-stems
- -piprazole
- Most common targets
- ATP4A, ATP4B (7), DRD2 (3), HTR1A (3), HTR2A (3), ADRA1A (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -prazole or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Dexlansoprazole | Approved | ATP4A, ATP4B | Potassium-transporting ATPase inhibitor |
| Lansoprazole | Approved | ATP4A, ATP4B | Potassium-transporting ATPase inhibitor |
| Pantoprazole | Approved | ATP4A, ATP4B | Potassium-transporting ATPase inhibitor |
| Rabeprazole | Approved | ATP4A, ATP4B | Potassium-transporting ATPase inhibitor |
| Esomeprazole | Approved | ATP4A, ATP4B | Potassium-transporting ATPase inhibitor |
| Omeprazole | Approved | ATP4A, ATP4B | Potassium-transporting ATPase inhibitor |
| Anaprazole | Phase 3 | — | — |
| Ilaprazole | Phase 3 | ATP4A, ATP4B | Potassium-transporting ATPase inhibitor |
| Tenatoprazole | Phase 2 | — | — |
| Azeloprazole | Phase 1 | — | — |
| Dexrabeprazole | — | — | — |
| Aripiprazole | Approved | DRD2, HTR1A, HTR2A | Dopamine D2 receptor partial agonist |
| Aripiprazole lauroxil | Approved | DRD2, HTR2A, HTR1A | Dopamine D2 receptor partial agonist |
| Brexpiprazole | Approved | DRD2, HTR1A, HTR2A | Dopamine D2 receptor partial agonist |
| Dapiprazole | Approved | ADRA1A | Alpha-1a adrenergic receptor antagonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO